Rezul'taty khirurgicheskogo lecheniya metastaticheskogo kolorektal'nogo raka posle provedeniya lekarstvennoy terapii s dobavleniem bevatsizumaba
- Authors: Sekacheva MI1, Polishchuk LO1, Bagmet NN1, Skipenko OG1
-
Affiliations:
- Issue: Vol 14, No 2 (2012)
- Pages: 38-41
- Section: Articles
- URL: https://modernonco.orscience.ru/1815-1434/article/view/29497
- ID: 29497
Cite item
Full Text
Abstract
References
- Adam R, Delvart V, Pascal G et al. Rescue surgery for unresectable colorectal liver metastases down staged by chemotherapy: a model to predict long term survival. Ann Surg 2004; 240: 644-57.
- Nordlinger B, Sorbye H, Glimelius B et al. Perioperative chemotherapy with FOLFOX4 and surgery vs surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup Trial 40983): a randomized controlled trial. Lancet 2008; 371: 1007-16.
- Pozzo C, Basso M, Cassano A et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 2004; 15 (6): 933-9.
- Saltz LB, Clarke S, Diaz-Rubio E et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 2008; 26: 2013-9.
- Kesmodel SB, Ellis LM, Lin E et al. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol 2008; 26: 5254-60.
- Blazer DG, Kishi Y, Maru DM et al. Pathologic response to preoperative chemotherapy: a new outcome endpoint after resection of hepatic colorectal metastases. J Clin Oncol 2008; 26: 5344-51.
- Chun YS, Vauthey JN, Boonsirikamchai P et al. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA 2009; 302 (21): 2338-44.
- Loupakis F, Bria E, Vaccaro V et al. Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials. J Exp Clin Cancer Res 2010; 26 (29): 58.
- Патютко Ю.И., Сагайдак И.В., Котельников А.Г. и др. Резекция печени: современные технологии при опухолевом поражении. Анналы хирург. гепатологии. 2010; 15 (2).